PFE (Pfizer) How high will it go? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go?

PFE 25.25

-0.7%

9:55 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BigKNY3 who wrote (4041)	7/8/1998 6:24:00 PM
From: Anthony Wong	Read Replies (3) of 9523

Vivus seeks partner in face of Viagra competition Wednesday July 8, 6:03 pm Eastern Time MOUNTAIN VIEW, Calif., July 8 (Reuters) - Drug company Vivus Inc. (VVUS - news) said Wednesday it is seeking a partner to promote its impotence drug Muse in the United States due to strong competition from the blockbuster drug Viagra . The company said in a statement it will restructure its sales staff resulting in a one-time second quarter charges of $6.5 million and make unspecified job cuts. Viagra, made by Pfizer Inc. (PFE - news) and the first oral drug for impotence, has become one of the most popular prescription drugs since its launch a few months ago. Sales of Vivus' Muse system, which involves placing a pellet into the tip of the penis, have declined since the launch of Viagra as Vivus fought a losing battle to convince consumers that its product works better on those with a moderate to severe problem. Vivus claims that its drug has fallen victim to the advertising frenzy attached to Viagra among both the public and the medical community. ''The primary care physician (PCP) (has become) an important component in the treatment of erectile dysfunction,'' President and Chief Executive Leland Wilson said in a statement. ''Due to patient demand generated by the media, many PCPs are actively prescribing erectile dysfunction treatments.'' The company said it will seek out a partner with strong contacts in the PCP market to revive Muse. Vivus said its 74 urology sales representatives will move to Alza Corp (AZA - news). Vivus was spun off as a separate public company from Alza in 1991. They will continue to sell Muse on a limited basis until December 31. Vivus has also terminated its agreement with Innovex Inc. (INVX - news), which had been providing a contract sales force. The moves are part of an effort to reduce costs and return to profits. The company said the job cuts would affect its administration, research and development, clinical and marketing departments. biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next